Armed with $36M A round, Johns Hopkins spinout Neuraly heads to PhI Parkinson's trial
A startup company spun out of Johns Hopkins says it’s been able to slow the progression of Parkinson’s disease in mice models — and with a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
